Search

everythinglearnresearchcommunity

for

Search:↓

Platelet-rich plasma (PRP) shows promise in skin and hair treatments but results vary with preparation methods.

Microneedling combined with other treatments significantly improves hair growth in people with hair loss and is safe.

Injecting a peptide-hyaluronic acid mix improved hair growth in men with hair loss and was safe.

sPLA2-IIE is crucial for normal hair follicle structure and skin health.

Exosomes show promise for improving wound healing, reducing aging signs, preventing hair loss, and lightening skin but require more research and better production methods.

Platelet-rich plasma (PRP) is effective in treating various skin conditions and improving hair density, thickness, and patient satisfaction, with lower relapse rates for Alopecia Areata.

Botulinum toxins are safe for various medical and cosmetic uses, but more research is needed for long-term safety and effectiveness in hair growth treatments.

Exosome treatment safely increases hair density in male patients with androgenetic alopecia.

New regenerative therapies show promise for treating hair loss.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.

Platelet-Rich Fibrin (PRF) can speed up healing in chronic wounds, improve hair density, and act as a natural filler for skin rejuvenation, but its use in hair loss treatment needs more evaluation.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Microneedling with platelet-rich plasma and minoxidil improves hair growth more than just minoxidil in men with hair loss.

Scientists have improved 3D models of human skin for research and medical uses, but still face challenges in perfectly replicating real skin.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Dermatoscopy and videodermatoscopy are useful and reliable for tracking treatment progress in various skin conditions.

The created skin model with melanoblasts improves the study of skin color and offers an alternative to animal testing.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Different lab conditions and light treatment methods change how human skin cells respond to light therapy.

Researchers created a new light source that improves chemical imaging by removing background noise.

Microneedling is promising for treating various skin issues but needs more research to confirm its effectiveness and safety.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

LED light therapy at 863 nm wavelength can slow down skin tumor growth and reduce inflammation in mice.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.